"System Medicine" Approach for Prevention Strategies for Comorbidities in Infertile Men

Launched by IRCCS SAN RAFFAELE · Dec 13, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring how a "system medicine" approach can help identify new markers and tools to create personalized strategies for preventing other health issues, known as comorbidities, in men who have infertility problems. The goal is to find ways to better understand and manage the overall health of infertile men, focusing specifically on those with primary male infertility.

To participate in this study, men must be over 18 years old, of Caucasian descent, and have a confirmed diagnosis of primary male infertility caused solely by male factors. Participants will need to sign a consent form to join the trial. They will not be able to participate if they have certain health conditions, like blood disorders, or if they have taken antibiotics in the past six months. Those who join can expect personalized assessments that will contribute to understanding their health better and potentially improve care for men facing infertility.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Signature of the informed consent;
• • Be adults aged \> 18;
• • Caucasian race;
• • Documented diagnosis of primary male infertility with pure male factor;
• Exclusion Criteria:
• • Failure to obtain informed consent;
• • Patients with a known history of haematological disease;
• • Patients undergoing antibiotic treatments in the last 6 months